Metabolism-Clinical and Experimental

Papers
(The H4-Index of Metabolism-Clinical and Experimental is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset918
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications822
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults282
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History244
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation232
Editorial Board173
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST162
Editorial Board162
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity160
Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis160
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors147
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice143
Molecular code of ferroptosis: emerging multi-dimensional modifications and therapeutic targets in hepatic disorders137
Corrigendum to “Emerging roles of arginine metabolism in skeletal health and disease” [Metabolism 2025 Nov 19:175:156451. / PMID: 41270967]135
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy135
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review131
Sarcopenia does not have adverse effects on insulin sensitivity in women with obesity127
Insulin Resistance: An APOE4 Equivalent for Human Cerebral Cortical Amyloid Deposition120
Cost–Benefit Management of Insulin Resistance: Combination of Phentermine and a Flexible Weight Loss Strategy in the Era of GLP-1 Agonists. Visible Benefits Shown After Six Months of Treatment112
Brown adipose tissue-derived metabolites and their role in regulating metabolism110
The role of active vitamin D in preventing sarcopenia—Authors' reply104
Sepsis-induced lipid droplet accumulation enhances antibacterial innate immunity through mechanisms dependent on DGAT-1 and interferon-beta103
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states102
Angiopoietin-like protein 8 mediates inflammation and fibrosis of tubular cells in diabetic kidney disease progression by interacting with Akt295
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy90
PCSK9 in metabolism and diseases88
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity85
PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis84
Consensus statement on vitamin D role in metabolic health82
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis80
Protein oxidation in non-exercising healthy adults under varying dietary conditions: Physiological determinants, effects on fuel partitioning, and implications for body weight regulation77
Fatty acid metabolism: The crossroads in intestinal homeostasis and tumor77
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients75
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study74
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease74
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men74
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease72
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells71
Comprehensive assessment of the causal effects and metabolite mediators of glucose-lowering drug targets on cardio-renal-liver-metabolic health70
Editorial Board70
Uncovering mechanisms of thiazolidinediones on osteogenesis and adipogenesis using spatial fluxomics68
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease68
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity66
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis65
Impact of fasting on the AMPK and PGC-1α axis in rodent and human skeletal muscle: A systematic review64
Exercise training increases skeletal muscle sphingomyelinases and affects mitochondrial quality control in men with type 2 diabetes64
PDAP1 reprograms fatty acid metabolism and drives malignant transformation via HSPA8-Mediated ERK/MAPK activation in hepatocellular carcinoma63
Metabolic and immune dysfunction at the crossroads between type 1 diabetes and neurodegeneration61
From liver to vasculature: An integrated view of cardiovascular risk in hepatic steatosis61
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]59
A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosis58
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications57
Role of mitochondria in pathogenesis and therapy of renal fibrosis56
Role of Coronary Artery Calcium in the Association Between Hormone Replacement Therapy Status and Incident Death and Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis56
Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and R56
Editorial Board56
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis56
0.11592602729797